As COVID-19 cases surge despite mass vaccination, it's time to focus on the vulnerable

1Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

The COVID-19 pandemic is an era-defining, international emergency impacting the global economy, politics and countless individual lives. People living with cancer have increased risk of hospitalisation and mortality from COVID-19. There are limited data regarding vaccine efficacy in people with cancer, with lack of empirical evidence to guide vaccine strategy in cancer patients fostering uncertainty. Vulnerable groups, for whom vaccination protection may be attenuated, now carry the greatest burden of risk amongst the population. The cancer community needs to reconsider the potential on-going impact of COVID-19 and develop and plan new programs of work to mitigate it. Multiple potential future scenarios now exist, ranging from full protection from COVID-19 for cancer patients via herd immunity to viral evolution for vaccine resistance and increased virulence. Defining those most vulnerable to COVID-19 post-vaccination will require largescale data and evidence to comprehensively identify factors that reduce vaccine efficacy. Once identified, protecting these groups through transmission and mortality risk reduction will become paramount. As the pandemic progresses, "protecting the vulnerable"may enable a return to normal for the majority, whilst still protecting individuals living with and beyond cancer who already live with the challenges of having a cancer diagnosis.

Author supplied keywords

References Powered by Scopus

Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

10864Citations
N/AReaders
Get full text

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

1148Citations
N/AReaders
Get full text

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: A prospective cohort study

904Citations
N/AReaders
Get full text

Cited by Powered by Scopus

COVID-19 therapy and vaccination: a clinical narrative review

11Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Little, M., Fittall, M., McKenzie, H., Tilby, M., Tripathy, A., & Lee, L. Y. W. (2021). As COVID-19 cases surge despite mass vaccination, it’s time to focus on the vulnerable. Ecancermedicalscience. ecancer Global Foundation. https://doi.org/10.3332/ecancer.2021.ed117

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

80%

Researcher 1

20%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

38%

Environmental Science 2

25%

Psychology 2

25%

Nursing and Health Professions 1

13%

Article Metrics

Tooltip
Mentions
References: 1

Save time finding and organizing research with Mendeley

Sign up for free